|
Re: MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 2 DM
|
1
|
Mannkind
|
Jun 17, 2013 09:00AM
|
|
Re: MannKind Corporation Implements BioPharm Systems’ Siebel Clinical Trial
|
|
Mannkind
|
Jul 23, 2013 10:45AM
|
|
Re: MannKind Corporation to Hold 2013 First Quarter Financial Results Conference Cal
|
2
|
Mannkind
|
May 03, 2013 08:59AM
|
|
Re: MannKind Corporation: Reasons to believe in the future article
|
|
Mannkind
|
Mar 20, 2012 09:25AM
|
|
Re: MannKind Receives “Market Perform” Rating from Wells Fargo (MNKD)
|
|
Mannkind
|
Mar 12, 2013 05:36PM
|
|
Re: MannKind Receives “Market Perform” Rating from Wells Fargo (MNKD)
|
1
|
Mannkind
|
Mar 12, 2013 09:59AM
|
|
Re: MannKind Rises After Inhaled Insulin Meets Goals in Study
|
|
Mannkind
|
Aug 14, 2013 12:50PM
|
|
Re: MannKind shares leap as web site says firm is a ripe takeover target
|
|
Mannkind
|
May 23, 2013 08:56AM
|
|
Re: MannKind Still Treading Water, So Why Are Investors Surfing?
|
|
Mannkind
|
Jun 17, 2013 10:09AM
|
|
Re: MannKind Trivia: Who Likes Word Problems
|
2
|
Mannkind
|
Feb 25, 2013 09:51AM
|
|
Re: MannKind Upgraded by JMP Securities to “Market outperform” (MNKD)
|
|
Mannkind
|
Aug 10, 2012 10:45AM
|
|
Re: MannKind's Afrezza And The Oramed Threat
|
|
Mannkind
|
May 23, 2013 08:47AM
|
|
Re: MannKind: If You Buy, When?
|
1
|
Mannkind
|
Jun 27, 2012 12:17PM
|
|
Re: MAP's Levadex Ready For FDA Approval
|
1
|
Mannkind
|
Feb 04, 2013 08:30AM
|
|
Re: Margaret attempting transparency?
|
3
|
Mannkind
|
Apr 25, 2013 12:06PM
|
|
Re: MARKET CURRENTS
|
1
|
Mannkind
|
Aug 27, 2012 06:10PM
|
|
Re: MARKET CURRENTS
|
|
Mannkind
|
Aug 28, 2012 03:22PM
|
|
Re: MBB, KTOS, CISG, SILU, DGICA, MNKD...
|
1
|
Mannkind
|
Dec 17, 2012 05:00PM
|
|
Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN
|
1
|
Mannkind
|
Mar 27, 2013 04:00PM
|
|
Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN
|
3
|
Mannkind
|
Mar 27, 2013 04:05PM
|
